Search our Database of Scientific Publications and Authors

I’m looking for a

    1734 results match your criteria Paget Disease Extramammary

    1 OF 35

    Survival analysis of patients with invasive extramammary Paget disease: implications of anatomic sites.
    BMC Cancer 2018 Apr 10;18(1):403. Epub 2018 Apr 10.
    Department of Urology, Shanghai 9th People's Hospital, Shanghai Jiao Tong University, School of Medicine, 639 Zhizaoju Rd, Shanghai, 200011, People's Republic of China.
    Background: Extramammary Paget disease (EMPD) is a rare malignant dermatosis with poorly defined outcomes. We investigated clinical characteristics of invasive EMPD at different anatomic sites and by subject demographics to determine prognostic factors for overall survival (OS).

    Methods: All patient data were collected from the Surveillance, Epidemiology, and End Results (SEER) program, 1973-2013, of the U. Read More

    Transcriptome analyses reveal FOXA1 dysregulation in mammary and extramammary Paget's disease.
    Hum Pathol 2018 Apr 6. Epub 2018 Apr 6.
    Department of Pathology, Shantou University Medical College, Shantou, Guangdong; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address:
    Paget's disease (PD) is an uncommon intraepithelial adenocarcinoma with unknown pathogenesis. There are two anatomic subtypes: mammary (MPD) and extramammary (EMPD). Little is known about their molecular characteristics. Read More

    Genital diseases in the mature woman.
    Clin Dermatol 2018 Mar - Apr;36(2):208-221. Epub 2017 Oct 3.
    Department of Dermatology, Alpert Medical School of Brown University, Providence, RI; Department of Dermatology, Medical School of Jundiaí, São Paulo, Brazil. Electronic address:
    Vulvovaginal conditions are common in mature women. This reflects age-related changes in immunity and skin barrier function of vulvovaginal tissues. Vaginal atrophy is commonly complicated by dryness and inflammation, which makes postmenopausal atrophic vaginitis a virtually ubiquitous condition. Read More

    The Role of Radiotherapy in Extramammary Paget Disease: A Systematic Review.
    Int J Gynecol Cancer 2018 Mar 17. Epub 2018 Mar 17.
    Objective/purpose: Extramammary Paget disease (EMPD) is a rare neoplasm of the skin generally affecting the anogenital area. Because of the low-frequency of the disease, no specific guidelines about the treatment strategy are available. Surgery is the recommended therapy for resectable and localized disease, but several other local treatments have been reported such as radiotherapy (RT). Read More

    Primary vulvar Paget disease - the importance of clinical suspicion.
    Dermatol Online J 2017 Oct 15;23(10). Epub 2017 Oct 15.
    Dermatology Department, Centro Hospitalar do Porto, Portugal.
    Extramammary Paget disease of the vulva is a rare condition that accounts for only 1-2% of vulvar malignancies and represents a frequent cause of misdiagnosis. It is most commonly seen in postmenopausal women. Clinically it is similar to Paget disease of the breast, appearing as red, well-demarcated eczematoid lesions, with slightly raised edges. Read More

    Efficacy of low-dose 5-fluorouracil/cisplatin therapy for invasive extramammary Paget's disease.
    J Dermatol 2018 Feb 14. Epub 2018 Feb 14.
    Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
    Extramammary Paget's disease (EMPD) is one of the cutaneous adenocarcinomas. The effective chemotherapy for advanced EMPD has not been established. This study was designed to evaluate the efficacy of combination 5-fluorouracil (500 mg/body, 7 days/week) and cisplatin (5 mg/body 5 days/week) for invasive EMPD. Read More

    Ectopic Extramammary Paget Disease Occurring on the Nose.
    Dermatol Surg 2018 Feb 5. Epub 2018 Feb 5.
    Department of Otolaryngology-Head and Neck Surgery, San Antonio Uniformed Services Health Education Consortium (SAUSHEC) San Antonio, Texas Department of Dermatology, Audie L. Murphy Memorial VA Hospital, San Antonio, Texas Department of Pathology, Audie L. Murphy Memorial VA Hospital, San Antonio, Texas Department of Otolaryngology-Head and Neck Surgery, San Antonio Uniformed Services Health Education Consortium (SAUSHEC) San Antonio, Texas.

    Extramammary Paget disease of the vulva: immunohistochemical analysis of neoangiogenesis and epithelial-mesenchymal transition markers expression.
    Diagn Pathol 2018 Jan 3;13(1). Epub 2018 Jan 3.
    Gynecological Oncology Unit - CRO - IRCCS, National Cancer Institute, Aviano, Italy.
    Background: Extra-mammary Paget's disease of the vulva (EMPDV) is an infrequent chronic disease that often recurs. The aim of the study was to assess the presence of neoangiogenesis and the expression of epithelial-mesenchymal transition (EMT) markers in EMPDV, and their potential correlation with stromal invasion.

    Methods: All the women consecutively treated for EMPDV at our Institute, between January 2011 and December 2014, were studied for neoangiogenesis, analysed by microvessel density (MVD) using antibodies against CD31 and CD34. Read More

    Extramammary Paget Disease of the Vulva: A Case Series Examining Treatment, Recurrence, and Malignant Transformation.
    Int J Gynecol Cancer 2018 Mar;28(3):632-638
    Objectives: Extramammary Paget disease (EMPD) of the vulva is a rare lesion with a high recurrence rate ranging from 12% to 61%. The rate of underlying adenocarcinoma varies, but in the largest series was reported at 4%. Given the rarity of the disease there is a paucity of data to optimize treatment. Read More

    Evaluation of mapping biopsies for extramammary Paget disease: A retrospective study.
    J Am Acad Dermatol 2017 Dec 23. Epub 2017 Dec 23.
    Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
    Background: Extramammary Paget disease (EMPD) sometimes shows an ill-defined border and an unexpectedly extended tumor spread beyond the clinical borders. Mapping biopsy is 1 approach for complete surgical removal, but its efficacy has remained controversial.

    Objective: We sought to evaluate mapping biopsies for EMPD. Read More

    Perianal Paget disease: a report of 2 cases.
    Ann Surg Treat Res 2017 Dec 1;93(6):336-341. Epub 2017 Dec 1.
    Division of Colorectal Surgery, Department of Surgery, Colorectal Cancer Clinic, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
    Extramammary Paget disease (EMPD) is a rare cutaneous neoplasm. Perianal Paget disease (PPD) is a subset of EMPD manifesting perianal lesions. Two cases of PPD in Severance Hospital are described in this article. Read More

    Reflectance confocal microscopy of mammary Paget disease.
    Dermatol Pract Concept 2017 Oct 31;7(4):75-80. Epub 2017 Oct 31.
    Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.
    Mammary Paget disease is the intraepidermal adenocarcinoma of the nipple area which is characterized usually by a well-demarcated eczematous plaque. Reflectance confocal microscopy (RCM), is an in vivo noninvasive diagnostic tool with a high-resolution imaging of the skin, almost comparable to conventional histology. RCM findings of Paget disease are limited in the literature. Read More

    Extramammary Paget's Disease Associated With Genital Wart and Lichen Sclerosus.
    Acta Med Iran 2017 Sep;55(9):591-593
    Department of Pathology, NYU Winthrop Hospital, Mineola, NY, USA.
    Extramammary Paget's disease is an uncommon intraepithelial adenocarcinoma in genital and perianal regions. Genital wart is the most common sexually transmitted disease caused by human papilloma viruses and vulval lichen sclerosus is chronic pruritic dermatitis in genital area which could be able to change to invasive squamous cell carcinoma. We report a patient who had simultaneous lichen sclerosus, genital wart and extramammary Paget's disease of the vulva. Read More

    Imiquimod 5% cream as a therapeutic option for extramammary Paget's disease.
    J Dermatol 2018 Feb 8;45(2):216-219. Epub 2017 Nov 8.
    Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
    A wide local excision is the standard treatment for extramammary Paget's disease (EMPD), though this treatment often leads to permanent anogenital mutilation and functional impairment. The purpose of our study is to evaluate the efficacy and safety of the topical application of imiquimod 5% cream for non-invasive EMPD. We examined nine patients with EMPD. Read More

    Benefits of Urologic-Dermatologic Consultations for the Diagnosis of Cutaneous Penile Lesions: A Prospective Study.
    Clin Genitourin Cancer 2018 Apr 5;16(2):e421-e424. Epub 2017 Oct 5.
    Department of Urology, Angers University Hospital, Angers, France.
    Introduction: We evaluated the benefits of a specialized consultation created in 2014 for cutaneous penile lesions.

    Materials And Methods: We performed a descriptive prospective study evaluating all patients sent for a monthly urologic-dermatologic consultation at a French university hospital from September 2014 to September 2015 for cutaneous penile lesions. All patients evaluated were included. Read More

    5-aminolevulinic acid (5-ALA) fluorescence-guided Mohs surgery resection of penile-scrotal extramammary Paget's disease.
    Biosci Trends 2017 Nov 16;11(5):595-599. Epub 2017 Oct 16.
    Department of Urology Research Institute, Huashan Hospital Affiliated to Fudan University.
    This report aims to evaluate the usefulness of 5-aminolevulinic acid (5-ALA) fluorescence-guided Mohs surgery resection of penile-scrotal extramammary Paget's disease for achieving maximum tumor resection. Between January 2014 and December 2015, 5 patients underwent surgical resection of a penile-scrotal extramammary Paget's disease in department of urology, Huashan hospital, Fudan University. All patients were coated with 5-ALA (concentration of 20%) throughout the scrotum and the visible range of the lesion plus a 2cm margin 3 hours before the induction of anesthesia. Read More

    [A Case of Secondary Extramammary Paget's Disease Aroundthe Cutaneous Stoma after Radical Cystectomy].
    Hinyokika Kiyo 2017 Sep;63(9):381-386
    The Department of Urology, Osaka Red Cross Hospital.
    We present a case of secondary extramammary Paget's disease around the cutaneous ureterostomy stoma after radical cystectomy. An 85-year-old man with bacillus calmette-guérin refractory high-grade urothelial carcinoma underwent radical cystectomy and cutaneous ureterostomy construction. After right ureter cancer diagnosis, he underwent right nephroureterectomy 3 years after the cystectomy. Read More

    Invasive Paget Disease of the Vulva.
    Int J Gynecol Cancer 2018 Jan;28(1):176-182
    Objective: Extramammary Paget disease of the vulva (EPDV) is a rare occurrence with an indolent and relapsing course. Progression to invasion occurs in 4% to 19% of cases. The aim of this study is to report clinical-pathological features and outcomes of patients treated for invasive EPDV. Read More

    Clinical Benefits of Preoperative Conventional Fluorescence Diagnosis in Surgical Treatment of Extramammary Paget Disease.
    Dermatol Surg 2018 Mar;44(3):375-382
    Department of Dermatology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
    Background: In extramammary Paget disease (EMPD), initial margins of surgical excision are difficult to determine preoperatively. Fluorescence diagnosis (FD) may have utility as a noninvasive method for delineating tumor boundaries.

    Objective: The relationship between FD-delineated borders and results of multiple scouting biopsies (MSBs) in EMPD was investigated, evaluating the potential clinical role of FD. Read More

    A matter of margins: Surgical and pathologic risk factors for recurrence in extramammary Paget's disease.
    Gynecol Oncol 2017 11 19;147(2):358-363. Epub 2017 Sep 19.
    Mayo Clinic, Division of Gynecologic Oncology, United States.
    Objectives: To determine surgical and pathologic variables associated with recurrence in extramammary Paget's disease (EMPD).

    Methods: Medical records of patients seeking care for EMPD from 1/1992-9/2015 were reviewed. Follow-up was restricted to 5years following primary surgery. Read More

    Chemokine Receptors CXCR4 and CXCR7 are Associated with Tumor Aggressiveness and Prognosis in Extramammary Paget Disease.
    J Cancer 2017 2;8(13):2471-2477. Epub 2017 Aug 2.
    Department of Urology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
    Chemokines are involved in many aspects of oncogenesis, including regulation of cancer cell growth, dissemination and host-tumor response. However, the potential of the chemokine receptors, CXCR4 and CXCR7, in serving as biomarkers in extramammary Paget's disease (EMPD) has been rarely examined. Expressions of CXCR4 and CXCR7 were evaluated in 92 EMPD specimens by immunohistochemistry. Read More

    Patients' Experiences With Extramammary Paget Disease: An Online Pilot Study Querying a Patient Support Group.
    Urology 2018 Jan 8;111:214-219. Epub 2017 Sep 8.
    Department of Urology, University of Washington Medical Center, Seattle, WA.
    Objective: To illustrate the heterogeneous care delivered to patients with extramammary Paget disease (EMPD), a rare and lethal malignancy with poorly described treatment methodologies, by characterizing the clinical and pathologic characteristics of an international patient support group.

    Materials And Methods: Institutional review board approval was obtained to develop and distribute a nonvalidated survey to patients from an international, online EMPD support group. The survey was developed to capture patient clinical and pathologic details and was distributed between January 2017 and February 2017. Read More

    Successful TS-1 monotherapy as the second-line treatment for advanced extramammary Paget's disease: A report of two cases.
    J Dermatol 2018 Jan 11;45(1):80-82. Epub 2017 Sep 11.
    Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
    There is no standard chemotherapeutic treatment for advanced extramammary Paget's disease, though the effectiveness of some chemotherapy regimens, including docetaxel, has been reported. In this report, we report that TS-1 monotherapy was effective in two patients with advanced extramammary Paget's disease after docetaxel treatment failure. TS-1 monotherapy may be useful as the second-line treatment for patients with advanced extramammary Paget's disease. Read More

    A rare case of metastatic extramammary Paget disease of the spine and review of the literature.
    J Clin Neurosci 2017 Nov 6;45:161-165. Epub 2017 Sep 6.
    Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address:
    Extramammary Paget disease is an intraepithelial neoplasm affecting cells rich in apocrine glands-often located in the vulvar, scrotal, or perianal region. It typically affects older patients, between the ages of 50 and 80years old, and is most often limited to the epidermis. A 47-year-old Asian male first presented with enlargement of the right inguinal lymph node. Read More

    The Paget Trial: A Multicenter, Observational Cohort Intervention Study for the Clinical Efficacy, Safety, and Immunological Response of Topical 5% Imiquimod Cream for Vulvar Paget Disease.
    JMIR Res Protoc 2017 Sep 6;6(9):e178. Epub 2017 Sep 6.
    Department of Obstetrics and Gynaecology, Radboud University Medical Center, Nijmegen, Netherlands.
    Background: Vulvar Paget disease is a rare skin disorder, which is most common in postmenopausal Caucasian women. They usually present with an erythematous plaque that may show fine or typical "cake icing" scaling or ulceration that may cause itching, pain, irritation, or a burning sensation. Although most cases are noninvasive, vulvar Paget disease may be invasive or associated with an underlying vulvar or distant adenocarcinoma. Read More

    GATA3 is a sensitive marker for primary genital extramammary paget disease: an immunohistochemical study of 72 cases with comparison to gross cystic disease fluid protein 15.
    Diagn Pathol 2017 Jul 10;12(1):51. Epub 2017 Jul 10.
    Department of Pathology and Immunology, Washington University School of Medicine, 660 S South Euclid Avenue Campus Box 8118, Saint Louis, MO, 63110, USA.
    Background: GATA-binding protein 3 (GATA3) has been identified as a sensitive marker for breast carcinoma but its sensitivity in primary genital extramammary Paget diseases (EMPDs) has not been well studied.

    Methods: Here we investigated immunohistochemical expression of GATA3 in 72 primary genital EMPDs (35 from female, 37 from male; 45 with intraepithelial disease only, 26 with both intraepithelial disease and invasive adenocarcinoma including 14 also metastasis, 1 with metastatic adenocarcinoma only for study). We also compared GATA3 to gross cystic disease fluid protein 15 (GCDFP15) for their sensitivity. Read More

    Spectrum of Changes in Anogenital Mammary-like Glands in Primary Extramammary (Anogenital) Paget Disease and Their Possible Role in the Pathogenesis of the Disease.
    Am J Surg Pathol 2017 Aug;41(8):1053-1058
    *Department of Pathology, Clinical Research and Practical Center for Specialized Oncological Care †Department of Pathology, Medical Faculty, Saint-Petersburg State University ‡Department of Pathology, Saint-Petersburg Medico-Social Institute ∥∥Department of Dermatology, Medical Military Academy, Saint Petersburg, Russia §PathWest Laboratory Medicine WA, QEII Medical Centre ∥School of Pathology and Laboratory Medicine, University of Western Australia, Nedlands ¶PathWest Laboratory Medicine WA, King Edward Memorial Hospital, Perth, WA, Australia #Sikl's Department of Pathology, Medical Faculty in Pilsen, Charles University in Prague **Bioptical Laboratory §§Department of Obstetrics and Gynecology, Charles University Medical Faculty Hospital, Pilsen, Czech Republic ††Miraca Life Science, Irving, TX ‡‡Department of Pathology, Division of Dermatopathology, Medical College of Wisconsin, Milwaukee, WI ¶¶Dermatopathology Unit, Department of Dermatology, Zurich University Hospital, Zurich, Switzerland.
    To determine whether a subset of primary extramammary Paget disease (EMPD) may originate in anogenital mammary-like glands (AGMLG), the authors studied 181 specimens of EMPD, detailing alterations in AGMLG. The latter were identified in 33 specimens from 31 patients. All patients were women, ranging in age from 38 to 93 years (median, 65 y). Read More

    Perianal Pagetoid Intraepithelial Carcinoma.
    Case Rep Gastroenterol 2017 Jan-Apr;11(1):109-113. Epub 2017 Mar 3.
    aDivision of Radiation Oncology, The Ottawa Hospital and the University of Ottawa, Ottawa, Ontario, Canada.
    Extramammary Paget disease (EMPD) involving the perianal region is rare and challenging to manage. Primary EMPD involves stand-alone noninvasive lesions within the epidermis, while secondary EMPD involves phenotypically similar lesions derived from separate underlying malignancies. Differentiating between primary and secondary EMPD is challenging when no underlying malignancies are detected during workup. Read More

    Extramammary Paget's disease of the oral mucosa and perioral skin.
    Oral Surg Oral Med Oral Pathol Oral Radiol 2017 Aug 11;124(2):e157-e163. Epub 2017 May 11.
    State Key Laboratory of Oral Diseases, Department of Oral Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, P.R. China. Electronic address:
    Extramammary Paget's disease (EMPD) is an unusual intraepidermal adenocarcinoma. Only 2 cases of EMPD in the oral mucosa have been reported previously. Here, we present the first report of a rare case of Paget's disease of the oral mucosa and perioral skin with extensive contiguous erythematous and erosive manifestations. Read More

    Intratumor dihydropyrimidine dehydrogenase mRNA expression levels are decreased in extramammary Paget's disease.
    Drug Discov Ther 2017 Jul 11;11(3):152-155. Epub 2017 Jul 11.
    Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University.
    S-1, a 5-fluorouracil (5-FU)-based anti-cancer agent, is an important drug for treating metastatic extramammary Paget's disease (EMPD). Although intratumor expression levels of 5-FU metabolism enzymes have been studied widely in many solid tumors, no studies have examined on the expression levels of thymidylate synthase (TS), orotate phosphoribosyl-transferase (OPRT) or dihydropyrimidine dehydrogenase (DPD) in skin cancers. The aim of this study was to estimate the intratumoral mRNA expression levels of these genes in EMPD by real time PCR. Read More

    Invasive Extramammary Paget Disease of the Vulva With Signet Ring Cell Morphology in a Patient With Signet Ring Cell Carcinoma of the Stomach: Report of a Case.
    Int J Gynecol Pathol 2018 Mar;37(2):147-151
    Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
    This report describes a rare case of invasive extramammary Paget disease of the vulva with signet ring cell morphology in a 58-yr-old woman with a history of signet ring cell carcinoma of the stomach. This case was initially misinterpreted as a metastatic gastric carcinoma to the vulva because an initial small, superficial biopsy specimen showed infiltration of signet ring cells in the dermis without intraepidermal Paget cells. However, a surgically resected specimen showed concordant immunophenotypes in both intraepidermal Paget cells and intradermal signet ring cell components with immunoreactivity to cytokeratin (CK) 7, CEA, and gross cystic disease fluid protein-15, and immunonegativity for CK20, MUC5AC, and MUC6. Read More

    Diagnostic Criteria in Intraepithelial Pagetoid Neoplasms: A Histopathologic Study and Evaluation of Select Features in Paget Disease, Bowen Disease, and Melanoma In Situ.
    Am J Dermatopathol 2017 Jun;39(6):419-427
    *Demonstrator at the Dermatology Department, Kasralainy Faculty of Medicine, Cairo, University, Egypt; †Visiting Research Fellow, Ackerman Academy of Dermatopathology, New York, NY; ‡Attending Dermatologist, Department of Dermatology, Dermatology Hospital of Southern Medical University, Guangdong Provincial Dermatology Hospital, China; §Junior Specialist, Department of Dermatology, University of California, Irvine, CA; ¶Attending Dermatologist, Department of Dermatology, Jose R. Reyes Memorial Medical Center, Manila; ‖Medical Student, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ; #Professor of Biostatistics, Department of Biostatistics and Epidemiology, National Cancer Institute, Cairo University, Cairo, Egypt; **Dermatopathologist, Dermpath Diagnostics New York, Port Chester, NY; and ††Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, SC.
    Background: Paget disease, Bowen disease, and malignant melanoma in situ are intraepidermal neoplasms, characterized by the presence of pagetoid scatter of atypical cells in the epidermis. This study reviewed the frequency of select histologic criteria to validate their usefulness in the histologic distinction between these entities.

    Methods: One hundred forty-four specimens with the diagnosis of Bowen disease, 144 specimens with Paget disease (mammary and extramammary), and 144 specimens with malignant melanoma in situ were examined microscopically to define frequencies of select histologic criteria present in each disease. Read More

    Handheld Reflectance Confocal Microscopy for the Detection of Recurrent Extramammary Paget Disease.
    JAMA Dermatol 2017 Jul;153(7):689-693
    Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
    Importance: Extramammary Paget disease (EMPD) is commonly refractory to surgical and nonsurgical therapies. Identifying recurrent or persistent EMPD is challenging because the disease is multifocal, and multiple blind scouting biopsies are usually performed in this setting. Handheld reflectance confocal microscopy (HRCM) has been used to diagnose and map primary EMPD and therefore may be used to identify EMPD recurrences. Read More

    A case of extramammary inguinal Paget disease in a male patient: surgical treatment with an abdominal advancement cutaneous flap.
    Acta Biomed 2017 Apr 28;88(1):79-81. Epub 2017 Apr 28.
    Extramammary Paget disease (EMPD) is a rare neoplasm. The clinical case of a 55-year-old man with a two-year history of a pruritic, painless erythematous skin rash on the inguinal region and scrotum is described. After a delay due to improper diagnosis and improper treatments, the patient came to the attention of the Division of plastic surgery. Read More

    Multiple concurrent primary extramammary Paget's disease.
    Malays Fam Physician 2016 30;11(1):18-21. Epub 2016 Apr 30.
    Department of Family Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Center Kuala Lumpur, Malaysia.
    Extramammary Paget's disease (EMPD) is a rare malignant disorder of the skin, which was described in as early as the nineteenth century. EMPD usually occurs as a single lesion in the apocrine sweat gland-bearing skin with abundant hair follicles. Here, we present an elderly man who suffered from a non-resolving chronic genital pruritus for 8 months. Read More

    Cervical metastases originating from a primary rectal adenocarcinoma due to a pagetoid spread.
    Hum Pathol 2017 10 28;68:184-188. Epub 2017 Apr 28.
    Department of Pathology, Radboud University Medical Center, 6500 HB, Nijmegen, the Netherlands.
    Vulvar Paget disease is a rare skin disorder, considered an in situ adenocarcinoma. It is characterized by intraepithelial Paget cells, of which the origin is unclear. About 75% of cases have a cutaneous origin; the other 25% originate from an intestinal or urological malignancy. Read More

    Paget's Disease of the Vulva: A Review of 20 Years' Experience.
    Int J Gynecol Cancer 2017 05;27(4):791-793
    *Department of Gyn Oncology, Hereford Hospital, Hereford; †Department of Gyn Oncology, University of Bristol, Bristol; and ‡Department of Gyn Oncology, St James's Institute of Oncology, Leeds, United Kingdom.
    Background: Extramammary Paget's disease is a rare condition, and the vulva is a common site for it to occur. Despite this, there is a paucity of literature on Paget's disease of the vulva (VPD). A Cochrane meta-analysis could not draw any conclusions on interventions in VPD. Read More

    Molecular subtyping of mammary-like adenocarcinoma of the vulva shows molecular similarity to breast carcinomas.
    Histopathology 2017 Sep 16;71(3):446-452. Epub 2017 Jun 16.
    Division of Anatomical Pathology, Vancouver General Hospital, University of British Columbia, Vancouver, Canada.
    Aims: Mammary-like adenocarcinoma (MLA) of the vulva is thought to be derived from vulvar mammary-like glands. The aim of this study was to characterize a series of MLAs by using an immunohistochemical algorithm that identifies the major molecular subtypes of breast cancer.

    Methods And Results: Seven cases of vulval MLA were stained for oestrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), Ki67, epidermal growth factor receptor (EGFR), cytokeratin (CK) 5, nestin, and inositol polyphosphate-4-phosphatase (INPP4b). Read More

    Modified weekly regimen of cisplatin, epirubicin and paclitaxel induced a durable response in two cases of metastatic extramammary Paget's disease.
    J Dermatol 2017 Oct 13;44(10):1148-1151. Epub 2017 Apr 13.
    Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
    Metastatic extramammary Paget's disease (EMPD) is a rare cancer with no standardized treatment. We report two cases of metastatic EMPD treated with a modified weekly PET (cisplatin, epirubicin and paclitaxel) regimen given biweekly (i.e. Read More

    Vulvar and Anal Intraepithelial Neoplasia: Terminology, Diagnosis, and Ancillary Studies.
    Adv Anat Pathol 2017 May;24(3):136-150
    Department of Pathology, Stanford University School of Medicine, Stanford, CA.
    Currently, it is recognized that there is an HPV-related and an HPV-independent pathway to developing squamous cell carcinomas (SCC) in the anus and vulva. The majority of precursor lesions and SCC in the anus and vulva are high-risk HPV-associated, with HPV16 the most common type. Given the morphologic overlap and biological equivalence of HPV-related preinvasive squamous lesions of the lower anogenital tract, a unified, 2-tiered histopathologic nomenclature is now recommended. Read More

    Podoplanin expression in peritumoral keratinocytes predicts aggressive behavior in extramammary Paget's disease.
    J Dermatol Sci 2017 Jul 27;87(1):29-35. Epub 2017 Mar 27.
    Department of Dermatology, Kyoto Prefectural University of Medicine, Kyoto, Japan. Electronic address:
    Background: Recent studies have demonstrated podoplanin expression in several tumors, which has been associated with lymph node metastasis and poor prognosis. Podoplanin expression in peritumoral cells such as cancer-associated fibroblasts also correlates with tumor progression in several cancers. However, podoplanin expression and its association with extramammary Paget's disease (EMPD) remain unclear. Read More

    Evaluation of positron emission tomography imaging to detect lymph node metastases in patients with extramammary Paget's disease.
    J Dermatol 2017 Aug 11;44(8):939-943. Epub 2017 Mar 11.
    Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
    Patients with extramammary Paget's disease (EMPD) have a relatively good prognosis, when spread of the tumor cells is limited to the epidermis. However, invasive EMPD has a poor prognosis, when the patients have regional lymph node metastasis. Detection of nodal metastasis is thus mandatory to manage EMPD. Read More

    1 OF 35